Safety and effectiveness of mirogabalin for CIPN induced by nab-paclitaxel in patients with pancreatic cancer

被引：0

作者：

Saito, Kei ^{[1
]}

Nakai, Yousuke ^{[1
,2
]}

Ishigaki, Kazunaga ^{[1
]}

Takahara, Naminatsu ^{[1
]}

Suzuki, Tatsunori ^{[1
]}

Hakuta, Ryunosuke ^{[1
,2
]}

Saito, Tomotaka ^{[1
]}

Hamada, Tsuyoshi ^{[1
]}

Mizuno, Suguru ^{[1
]}

Kogure, Hirofumi ^{[1
]}

Fujishiro, Mitsuhiro ^{[1
]}

机构：

[1] Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Tokyo, Japan

[2] Univ Tokyo, Dept Endoscopy & Endoscop Surg, Grad Sch Med, Tokyo, Japan

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷

关键词：

D O I：

10.1016/j.annonc.2022.05.262

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P21-17

引用

页码：S520 / S520

页数：1

共 50 条

[31] Gemcitabine (Gem) and nab-paclitaxel (nab-P) in patients (pts) with refractory advanced pancreatic cancer
Palacio, Sofia
Akunyili, Ikechukwu Immanuel
Ernani, Vinicius
Macintyre, Jessica
Merchan, Jaime R.
Pollack, Terri
Reis, Isildinha
Restrepo, Maria H.
Lima, Caio Max S. Rocha
Hosein, Peter Joel
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
[32] Gemcitabine (G) and nab-paclitaxel (nab-P) in patients with refractory advanced pancreatic cancer (PC).
Ernani, Vinicius
Akunyili, Ikechukwu Immanuel
Hosein, Peter Joel
Macintyre, Jessica
Lima, Caio Max S. Rocha
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
[33] Efficacy and Safety of Paclitaxel/nab-paclitaxel Chemotherapy for Patients With Relapsed Small Cell Lung Cancer
Matsui, Yohei
Yamada, Tadaaki
Morimoto, Kenji
Katayama, Yuki
Hiranuma, Osamu
Shiotsu, Shinsuke
Tamiya, Nobuyo
Takeda, Takayuki
Morimoto, Yoshie
Iwasaku, Masahiro
Tokuda, Shinsaku
Takayama, Koichi
ANTICANCER RESEARCH, 2022, 42 (10) : 4921 - 4928
[34] Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Von Hoff, Daniel D.
Ervin, Thomas
Arena, Francis P.
Chiorean, E. Gabriela
Infante, Jeffrey
Moore, Malcolm
Seay, Thomas
Tjulandin, Sergei A.
Ma, Wen Wee
Saleh, Mansoor N.
Harris, Marion
Reni, Michele
Dowden, Scot
Laheru, Daniel
Bahary, Nathan
Ramanathan, Ramesh K.
Tabernero, Josep
Hidalgo, Manuel
Goldstein, David
Van Cutsem, Eric
Wei, Xinyu
Iglesias, Jose
Renschler, Markus F.
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (18): : 1691 - 1703
[35] A modified regimen of nab-paclitaxel and gemcitabine in advanced pancreatic cancer
Osman, M. A. M.
McDermott, R.
Fennelly, D.
ANNALS OF ONCOLOGY, 2016, 27
[36] Initial Experience with Nab-Paclitaxel for Patients with Advanced Gastric Cancer: Safety and Efficacy
Kanazawa, Yoshikazu
Fujita, Itsuo
Kakinuma, Diasuke
Arai, Hiroki
Matsuno, Kunihiko
Shimoda, Tomohiro
Ko, Kazuhide
Kato, Shunji
Uchida, Eiji
ANTICANCER RESEARCH, 2017, 37 (05) : 2715 - 2720
[37] Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer
Cullis, Jane
Siolas, Despina
Avanzi, Antonina
Barui, Sugata
Maitra, Anirban
Bar-Sagi, Dafna
CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03) : 182 - 190
[38] Effect of Preoperative Nab-paclitaxel and Gemcitabine on Pancreatic Cancer Stroma
Ishido, K.
Kimura, N.
Wakiya, T.
Nagase, H.
Odagiri, T.
Mitsuhashi, Y.
Goto, S.
Yoshizawa, T.
Kijima, H.
Hakamada, K.
PANCREAS, 2019, 48 (10) : 1451 - 1451
[39] Safety and efficacy of first-line gemcitabine plus nab-paclitaxel for elderly metastatic pancreatic cancer patients
Pecora, I.
Vivaldi, C.
Rovesti, G.
Catanese, S.
Salani, F.
Gardini, A. Casadei
Massa, V.
Bernardini, L.
Riggi, M.
Andrikou, K.
Rapposelli, I.
Formica, V.
Cesario, S.
Caccese, M.
Lencioni, M.
Vasile, E.
Falcone, A.
Fornaro, L.
ANNALS OF ONCOLOGY, 2020, 31 : S151 - S151
[40] Safety and Efficacy of Gemcitabine Plus Nab-Paclitaxel for Metastatic Pancreatic Cancer Patients Undergoing Biliary Stent Placement
Tadahisa Inoue
Mayu Ibusuki
Rena Kitano
Kazumasa Sakamoto
Satoshi Kimoto
Yuji Kobayashi
Tomohiko Ohashi
Yoshio Sumida
Yukiomi Nakade
Kiyoaki Ito
Masashi Yoneda
Digestive Diseases and Sciences, 2022, 67 : 3298 - 3304

← 1 2 3 4 5 →